亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

武漢嘉靈醫藥化工有限公司  

醫藥原料,醫藥中間體,化工中間體

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:徐經理
  • 電話:027-59222350
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 左旋肉堿原料廠家,左旋肉堿原料藥
左旋肉堿原料廠家,左旋肉堿原料藥
單價 2.00 / 公斤對比
銷量 暫無
發貨 湖北武漢市付款后3天內
庫存 580公斤起訂1公斤
品牌 佳靈
型號 原料
規格 醫藥級
過期 長期有效
更新 2013-07-14 09:46
 
詳細信息

左旋肉堿原料廠家

15972030797----------------15972030797--------------15972030797--------------15972030797-----------------------15972030797-----------------------15972030797-------------------15972030797

英文名稱: L(-)-Carnitine

CAS號: 541-15-1

分子式: C7H15NO3

分子量: 161.2

化學性質 白色結晶或透明粉末,熔點200℃(分解)。比旋度 -31.19

水分   0.41

酸堿度 5.5~9.5 7.50

熾燒殘渣   0.07

殘留丙酮量 0.02

砷 <1ppm

氯化物(Cl)<0.02

重金屬 <10ppm

含量:99%

包裝:25kg紙板桶

質量標準:USP 32

用途 用于藥物、營養保健品、功能飲料、飼料添加劑等

©2025 武漢嘉靈醫藥化工有限公司 版權所有   技術支持:化工網   訪問量:7263  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |